Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Oyster Point Pharma, Inc. | q4-19ex322.htm |
| EX-32.1 - EX-32.1 - Oyster Point Pharma, Inc. | q4-19ex321.htm |
| EX-31.2 - EX-31.2 - Oyster Point Pharma, Inc. | q4-19ex312.htm |
| EX-31.1 - EX-31.1 - Oyster Point Pharma, Inc. | q4-19ex311.htm |
| EX-4.1 - EX-4.1 - Oyster Point Pharma, Inc. | q4-19ex41.htm |
| 10-K - 10-K - Oyster Point Pharma, Inc. | oyst-20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-234416) of Oyster Point Pharma, Inc. of our report dated February 27, 2020 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Florham Park, New Jersey
February 27, 2020